Videos

7 Diagnostic and Genomic Stocks Storming Into October

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Articles You May Like

Steelmakers may benefit from Trump trade salvos, but Wall Street warns of longer-term headwinds
Hochul touts targeted tax cuts in New York state budget plan
Trump signs order establishing a sovereign wealth fund that he says could buy TikTok
Bank of England cuts interest rate to 4.5% and halves 2025 growth forecast
Vanguard announces fee cuts for nearly 100 funds, including ETFs with billions of dollars in assets